Skip to main content
. 2020 Sep 16;16(15):2938–2950. doi: 10.7150/ijbs.47051

Figure 6.

Figure 6

Lnc-MCEI mediated the chemosensitivity of ESCC by targeting miR-6759-5p/IGF2/PI3K/AKT axis. A and B. The protein expression levels of IGF2, phosphorylated AKT (p-AKT) and total AKT (t-AKT) in KYSE-30 and EC109 cells treated with si-lnc-MCEI alone or combined with miR-6759-5p inhibitor. C. MTT assays were performed to examine the cell proliferation in KYSE-30 cells treated with si-lnc-MCEI, DDP, IGF2 plasmids (IGF2) or the PI3K inhibitor LY294002 (LY). D. The protein expression levels of p-AKT and t-AKT in KYSE-30 with the indicated treatments. *P < 0.05.